Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. | Vanda Pharmaceuticals’ ...
JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service ...
Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. | ...
Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...
The investment bank Jefferies had been running its healthcare conference in London for 14 years as a reasonably intimate ...
Cornerstone Robotics secured about $200 million in its second round of financing this year, which the Hong Kong-based company ...
Medtronic posted a slate of strong quarterly financial results this morning, with its cardiovascular device portfolio pushing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback